CAD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -18.26 Million USD | -16.37% |
2022 | -2.4 Million USD | 6.4% |
2021 | -7.23 Million USD | -38.51% |
2020 | -20.6 Million USD | 75.42% |
2019 | -168.29 Million USD | -1053.13% |
2018 | -2.28 Million USD | -76.85% |
2017 | -3.19 Million USD | -733.95% |
2016 | -12.78 Million USD | -20.43% |
2015 | -128.65 Thousand USD | 47.77% |
2014 | -246.32 Thousand USD | -145.26% |
2013 | -100.43 Thousand USD | 73.11% |
2012 | -373.43 Thousand USD | 38.3% |
2011 | -605.25 Thousand USD | 50.02% |
2010 | -1.21 Million USD | -6.88% |
2009 | -1.13 Million USD | -335.61% |
2008 | 480.86 Thousand USD | -90.81% |
2007 | 5.23 Million USD | 3324.13% |
2006 | -162.31 Thousand USD | -2754.62% |
2005 | -5685.91 USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -3.52 Million USD | 30.1% |
2024 Q2 | -3.21 Million USD | 40.08% |
2023 FY | - USD | -16.37% |
2023 Q4 | -3.97 Million USD | 48.16% |
2023 Q3 | -7.65 Million USD | -94.66% |
2023 Q2 | -3.93 Million USD | 7.59% |
2023 Q1 | -4.25 Million USD | 45.93% |
2022 Q1 | 659 Thousand USD | 105.68% |
2022 Q3 | 923 Thousand USD | -69.67% |
2022 FY | - USD | 6.4% |
2022 Q2 | 3.04 Million USD | 361.76% |
2022 Q4 | -7.87 Million USD | -952.98% |
2021 Q4 | -11.6 Million USD | -33057.14% |
2021 FY | - USD | -38.51% |
2021 Q1 | 1.4 Million USD | 120.33% |
2021 Q2 | 3.56 Million USD | 153.99% |
2021 Q3 | -35 Thousand USD | -100.98% |
2020 FY | - USD | 75.42% |
2020 Q2 | 611 Thousand USD | 116.15% |
2020 Q3 | 3.12 Million USD | 411.78% |
2020 Q4 | -6.89 Million USD | -320.5% |
2020 Q1 | -3.78 Million USD | 74.5% |
2019 Q2 | -2.1 Million USD | 21.5% |
2019 Q4 | -14.84 Million USD | -147.32% |
2019 Q1 | -2.68 Million USD | -103.24% |
2019 Q3 | -6 Million USD | -185.12% |
2019 FY | - USD | -1053.13% |
2018 Q1 | -584.52 Thousand USD | -3859.05% |
2018 Q3 | 559.86 Thousand USD | -51.53% |
2018 FY | - USD | -76.85% |
2018 Q4 | -1.31 Million USD | -335.6% |
2018 Q2 | 1.15 Million USD | 297.59% |
2017 Q3 | -8527.49 USD | 54.32% |
2017 Q4 | -14.76 Thousand USD | -73.14% |
2017 Q2 | -18.66 Thousand USD | 63.19% |
2017 Q1 | -50.7 Thousand USD | 10.62% |
2017 FY | - USD | -733.95% |
2016 Q4 | -56.72 Thousand USD | -146.79% |
2016 Q3 | -22.98 Thousand USD | 4.44% |
2016 Q1 | -271.75 Thousand USD | -986.91% |
2016 Q2 | -24.05 Thousand USD | 91.15% |
2016 FY | - USD | -20.43% |
2015 Q2 | 206.01 Thousand USD | 373.07% |
2015 Q4 | -25 Thousand USD | 1.08% |
2015 Q3 | -25.27 Thousand USD | -112.27% |
2015 FY | - USD | 47.77% |
2015 Q1 | -75.44 Thousand USD | -50.65% |
2014 Q4 | -50.07 Thousand USD | 53.03% |
2014 FY | - USD | -145.26% |
2014 Q1 | -68.36 Thousand USD | -3846.49% |
2014 Q2 | -31.51 Thousand USD | 53.91% |
2014 Q3 | -106.62 Thousand USD | -238.38% |
2013 FY | - USD | 73.11% |
2013 Q4 | -1732.31 USD | 82.41% |
2013 Q2 | -11.46 Thousand USD | 92.03% |
2013 Q1 | -143.78 Thousand USD | -97.6% |
2013 Q3 | -9850.99 USD | 14.07% |
2012 FY | - USD | 38.3% |
2012 Q1 | -108.66 Thousand USD | -21.32% |
2012 Q2 | -82.89 Thousand USD | 23.71% |
2012 Q3 | -209.22 Thousand USD | -152.39% |
2012 Q4 | -72.76 Thousand USD | 65.22% |
2011 Q2 | -209.9 Thousand USD | 50.4% |
2011 Q4 | -89.57 Thousand USD | 57.14% |
2011 FY | - USD | 50.02% |
2011 Q3 | -209 Thousand USD | 0.43% |
2011 Q1 | -423.18 Thousand USD | -71.73% |
2010 FY | - USD | -6.88% |
2010 Q3 | -277.51 Thousand USD | -9.7% |
2010 Q2 | -252.96 Thousand USD | 44.47% |
2010 Q1 | -455.53 Thousand USD | -95.89% |
2010 Q4 | -246.42 Thousand USD | 11.2% |
2009 Q3 | -186.61 Thousand USD | 8.73% |
2009 Q1 | -108.4 Thousand USD | -115.11% |
2009 FY | - USD | -335.61% |
2009 Q4 | -232.55 Thousand USD | -24.62% |
2009 Q2 | -204.45 Thousand USD | -88.61% |
2008 Q2 | -249.89 Thousand USD | 15.11% |
2008 Q3 | -185.66 Thousand USD | 25.7% |
2008 Q1 | -294.37 Thousand USD | -32.46% |
2008 FY | - USD | -90.81% |
2008 Q4 | 717.27 Thousand USD | 486.33% |
2007 Q3 | -236 Thousand USD | 75.67% |
2007 Q4 | -222.23 Thousand USD | 5.84% |
2007 Q1 | -87.87 Thousand USD | -82.03% |
2007 Q2 | -970.21 Thousand USD | -1004.05% |
2007 FY | - USD | 3324.13% |
2006 Q4 | -48.27 Thousand USD | -538.59% |
2006 Q2 | -10.37 Thousand USD | 0.0% |
2006 FY | - USD | -2754.62% |
2006 Q3 | -7559.71 USD | 27.11% |
2005 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | -200.657% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -808.285% |
Blueberries Medical Corp. | -1.22 Million CAD | -1394.612% |
The BC Bud Corporation | -1.19 Million CAD | -1426.822% |
BioNxt Solutions Inc. | -6.48 Million CAD | -181.605% |
CordovaCann Corp. | -1.6 Million CAD | -1039.448% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | -596.068% |
Captor Capital Corp. | 2.42 Million CAD | 854.222% |
City View Green Holdings Inc. | -2.01 Million CAD | -806.496% |
1CM Inc. | 1.31 Million CAD | 1490.228% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -73553.854% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -726.89% |
IM Cannabis Corp. | -2.79 Million CAD | -554.516% |
Lobe Sciences Ltd. | -4.4 Million CAD | -314.807% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -4555.853% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -471.907% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 1699.596% |
Ovation Science Inc. | -778.83 Thousand CAD | -2244.665% |
Pharmadrug Inc. | -1.33 Million CAD | -1267.852% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | -201.532% |
RAMM Pharma Corp. | -6.3 Million CAD | -189.761% |
RIV Capital Inc. | -20.28 Million CAD | 9.957% |
Revive Therapeutics Ltd. | -5.59 Million CAD | -226.38% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 76.465% |
SLANG Worldwide Inc. | -2.95 Million CAD | -518.867% |
1933 Industries Inc. | -10.03 Million CAD | -82.01% |
Red Light Holland Corp. | -5.25 Million CAD | -247.441% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -2277.756% |
Xebra Brands Ltd. | -1.49 Million CAD | -1121.475% |
Adastra Holdings Ltd. | -1.41 Million CAD | -1193.946% |